221st ACS. Division of Medicinal Chemistry - first-time disclosure of clinical candidates.
The 221st ACS meeting in San Diego, USA, saw a symposium entitled 'First-time disclosure of clinical candidates', the inaugural presentation of this symposium in the society's 125-year history. Dr Balu N Balasubramanian (Bristol-Myers Squibb Co, USA), Chair of this well-attended symposium of five papers, remarked that he hoped that this symposium will become a regular event at ACS conferences.
Current Drugs Ltd, Middlesex House, 34-42 Cleveland Street, London, W1T 4LB, UK. richard.cox@current-drugs.com
R
R
Cox